{"text": "LIPI was an independent prognostic factor of chemotherapy for adenocarcinoma with wild-type EGFR and of EGFR-TKI for NSCLC harboring mutant EGFR. Thus, LIPI was not a specific biomarker for ICI therapy, but a useful biomarker for chemotherapy and EGFR-TKI therapy in specific subsets of NSCLC.", "denotations": [{"id": "T1", "obj": "disease", "span": {"begin": 62, "end": 76}}, {"id": "T2", "obj": "gene", "span": {"begin": 92, "end": 96}}, {"id": "T3", "obj": "disease", "span": {"begin": 117, "end": 122}}]}
